The Stochastic Oscillator for BEAM moved into oversold territory on November 12, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
The 10-day moving average for BEAM crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 78%.
Following a +4.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where BEAM advanced for three days, in 198 of 260 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The 10-day RSI Indicator for BEAM moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In 21 of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at 84%.
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BEAM as a result. In 76 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for BEAM turned negative on November 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 44 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
BEAM moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BEAM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
BEAM broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.555) is normal, around the industry mean (3.498). P/E Ratio (-38.275) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (15.314) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. BEAM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BEAM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The Stochastic Oscillator for ELDN moved into oversold territory on November 12, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
The Moving Average Convergence Divergence (MACD) for ELDN just turned positive on October 21, 2026. Looking at past instances where ELDN's MACD turned positive, the stock continued to rise in 39 of 43 cases over the following month. The odds of a continued upward trend are 90%.
The 10-day moving average for ELDN crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 19 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +16.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELDN advanced for three days, in 220 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
The 10-day RSI Indicator for ELDN moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 20 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ELDN as a result. In 78 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
ELDN moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for ELDN moved below the 200-day moving average on October 09, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELDN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
ELDN broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ELDN entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. ELDN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.412) is normal, around the industry mean (3.498). P/E Ratio (-2.894) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELDN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
BEAM | ELDN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 17 | 40 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | 72 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 100 | |
PRICE GROWTH RATING 1..100 | 52 | 59 | |
P/E GROWTH RATING 1..100 | 45 | 98 | |
SEASONALITY SCORE 1..100 | n/a | 30 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BEAM's Valuation (5) in the null industry is significantly better than the same rating for ELDN (72) in the Pharmaceuticals Major industry. This means that BEAM’s stock grew significantly faster than ELDN’s over the last 12 months.
BEAM's Profit vs Risk Rating (100) in the null industry is in the same range as ELDN (100) in the Pharmaceuticals Major industry. This means that BEAM’s stock grew similarly to ELDN’s over the last 12 months.
BEAM's SMR Rating (92) in the null industry is in the same range as ELDN (100) in the Pharmaceuticals Major industry. This means that BEAM’s stock grew similarly to ELDN’s over the last 12 months.
BEAM's Price Growth Rating (52) in the null industry is in the same range as ELDN (59) in the Pharmaceuticals Major industry. This means that BEAM’s stock grew similarly to ELDN’s over the last 12 months.
BEAM's P/E Growth Rating (45) in the null industry is somewhat better than the same rating for ELDN (98) in the Pharmaceuticals Major industry. This means that BEAM’s stock grew somewhat faster than ELDN’s over the last 12 months.
| BEAM | ELDN | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 84% | 1 day ago 71% |
| Stochastic ODDS (%) | 1 day ago 80% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 89% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 83% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 88% |
| TrendMonth ODDS (%) | 1 day ago 82% | 1 day ago 88% |
| Advances ODDS (%) | 4 days ago 76% | 4 days ago 88% |
| Declines ODDS (%) | 11 days ago 84% | 1 day ago 88% |
| BollingerBands ODDS (%) | 1 day ago 88% | 1 day ago 88% |
| Aroon ODDS (%) | N/A | 1 day ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BEAM’s FA Score shows that 1 FA rating(s) are green while ELDN’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BEAM’s TA Score shows that 3 TA indicator(s) are bullish while ELDN’s TA Score has 4 bullish TA indicator(s).
BEAM (@Biotechnology) experienced а -7.11% price change this week, while ELDN (@Biotechnology) price change was -3.86% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.04%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -16.99%.
BEAM is expected to report earnings on Mar 02, 2027.
ELDN is expected to report earnings on Nov 13, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.
| Ticker / NAME | Correlation To BEAM | 1D Price Change % | ||
|---|---|---|---|---|
| BEAM | 100% | -6.90% | ||
| CRSP - BEAM | 77% Closely correlated | -6.84% | ||
| NTLA - BEAM | 70% Closely correlated | -7.54% | ||
| EDIT - BEAM | 67% Closely correlated | -10.08% | ||
| PRME - BEAM | 65% Loosely correlated | -9.53% | ||
| RXRX - BEAM | 60% Loosely correlated | -7.24% | ||
More | ||||
A.I.dvisor indicates that over the last year, ELDN has been loosely correlated with EDIT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ELDN jumps, then EDIT could also see price increases.
| Ticker / NAME | Correlation To ELDN | 1D Price Change % | ||
|---|---|---|---|---|
| ELDN | 100% | -11.42% | ||
| EDIT - ELDN | 50% Loosely correlated | -10.08% | ||
| BEAM - ELDN | 48% Loosely correlated | -6.90% | ||
| NTLA - ELDN | 47% Loosely correlated | -7.54% | ||
| MGX - ELDN | 46% Loosely correlated | -5.59% | ||
| PRME - ELDN | 43% Loosely correlated | -9.53% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SETH | 39.38 | 1.15 | +3.01% |
| ProShares Short Ether ETF (SETH) | |||
| KSA | 36.13 | 0.09 | +0.25% |
| iShares MSCI Saudi Arabia ETF (KSA) | |||
| EAGL | 36.01 | -0.20 | -0.55% |
| Eagle Capital Select Equity ETF (EAGL) | |||
| ACKY | 17.62 | -0.16 | -0.91% |
| VistaShares Target 15 ACKtivist Distribution ETF (ACKY) | |||
| EDF | 4.32 | -0.10 | -2.26% |
| Virtus Stone Harbor Emerging Markets Income Fund | |||